Barinthus Biotherapeutics plc
BRNS
$0.74-2.50%
End of day · as of Oct 16, 2026, 5:16 AM ET
Mkt cap
$38.16M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (TTM)
$-1.02
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
-0.77
Div yield
N/A
Sector
Healthcare
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Latest reported BRNS revenue for 2025-12-31 was $0. Net income was -$66.4M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. BRNS currently screens at market cap $38.2M.
Use this BRNS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BRNS income, balance, and cash tables.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company in the Healthcare sector.
Latest cached Barinthus Biotherapeutics plc (BRNS) net income for Dec 31, 2025 was -$66.4M. Statements: https://lician.com/financials/brns
Barinthus Biotherapeutics plc (BRNS) market capitalization is $38.2M on the latest cached snapshot.
Barinthus Biotherapeutics plc (BRNS) cached previous close $0.76; day range $0.64 – $0.76; volume 376,145. Session quote: https://lician.com/quote/brns
Barinthus Biotherapeutics plc (BRNS) latest cached earnings event is "BRNS earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached BRNS filing is 8-K · Sep 9, 2026. Filings: https://lician.com/sec/brns